References
- Wittes , RE . 1987 . Paying for patient care in treatment research— who is responsible? . Cancer Treatment Reports , 71 : 107 – 113 .
- Li , FP , Danahy , J and Geldman , R . 1984 . Utility of differential leucocyte counts in cancer management . JAMA , 252 : 1312 – 1314 .
- Humphrey , LJ and Eiseman , B . 1982 . “ Breast cancer ” . In Follow‐up of the Cancer Patient. , Edited by: Eiseman , B , Robinson , W and Steele , G . 110 – 114 . New York : Thieme‐Stratton, Inc. .
- Tempero , M , Peterson , PJ , Zetterman , RK , Lemon , H. and Guerney , J . 1982 . Detection of metastatic liver disease: Use of liver scan and biochemical liver tests . JAMA , 248 : 1329 – 1332 .
- Berry , RJ and Bryan , G . 1978 . Dare we count the cost of cancer chemotherapy? . Lancet , Sept. 2 : 516 – 518 .
- Yarbro , JW and Mortenson , LE . 1985 . The need for diagnosis‐related group 471 . JAMA , 253 : 684 – 4585 .
- Davis , CK . 1985 . The impact of prospective payment on clinical research . JAMA , 253 : 686 – 687 .
- Tiemey , WM , Miller , ME and McDonald , CJ . 1990 . The effect on test ordering of informing physicians of the changes for outpatient diagnostic tests . New Engl J Med , 332 : 1499 – 1504 .
- Rahman , F . 1990 . A doctor's remedy . Newsweek , April 9 : 10
- Rees , GJG . 1985 . cost‐effectiveness in oncology . Lancet , December 21/28 : 1405 – 1407 .
- Eddy , DM . 1990 . What do we do about costs? . JAMA , 264 : 1161 – 1170 .
- Schapira , DV and Urban , N . 1991 . A minimalist policy for breast cancer surveillance . JAMA , 265 : 380 – 282 .
- Wertheimer , MD . 1991 . Against minimalism in breast cancer follow‐up . JAMA , 265 : 396 – 397 .
- Regents' Professor of Medicine, Masonic Professor of Oncology, University of Minnesota Medical School.